"Our oncologists are actively engaged in clinical trials and offer personalized care at the Marshfield Clinic Cancer Center-Stevens Point. This, along with coordinated care to guide you through the process, is why we are the number one provider of cancer care in the heart of Wisconsin."

During the past decade, Marshfield Clinic Cancer Care at Saint Michael's Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 22 clinical trials were completed, i.e. on average, 244.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marshfield Clinic Cancer Care at Saint Michael's Hospital" #1 sponsor was "SWOG Cancer Research Network" with 13 trials, followed by "National Cancer Institute (NCI)" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Gynecologic Oncology Group" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshfield Clinic Cancer Care at Saint Michael's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator, "Medivation, Inc." with 1 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Marshfield Clinic Cancer Care at Saint Michael's Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Stage IIIA Fallopian Tube Cancer" (4 trials), "Stage IIIA Ovarian Cancer" (4 trials), "Stage IIIA Primary Peritoneal Cancer" (4 trials) and "Stage IIIB Fallopian Tube Cancer" (4 trials). Many other conditions were trialed in "Marshfield Clinic Cancer Care at Saint Michael's Hospital" in a lesser frequency.

Most popular intervention types in "Marshfield Clinic Cancer Care at Saint Michael's Hospital" are "Drug" (25 trials), "Other" (17 trials), "Biological" (8 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Docetaxel" (4 trials), "Paclitaxel" (3 trials), "Quality-of-Life Assessment" (3 trials) and "bortezomib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Marshfield Clinic Cancer Care at Saint Michael's Hospital" are 20 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Marshfield Clinic Cancer Care at Saint Michael's Hospital". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Marshfield Clinic Cancer Care at Saint Michael's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Marshfield Clinic Cancer Care at Saint Michael's Hospital, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".